Search

Terri L Mininni

from Peyton, CO
Age ~65
Get Report
Also known as:
Terri Lynn Mininni, Terri L Minnini, Terri M Joseph
Related to:
Gina MininniKathy S Torres, 54Robin Jenkins, 45Gregory Jenkins, 43Abigail O'Brien, 34Douglas D Jenkins, 71
Connected to:
Linda A Mininno, 65Charlie A Minino, 38Erik P Minino, 52Kimberly A Minino, 43Silvye M Minino, 48Jerry Minio, 52Rose Minio, 105Bernadine J Minion, 97Dave D Minion, 82Joy D Minion, 75

Terri Mininni Phones & Addresses

  • Peyton, CO
  • New Hartford, NY
  • 1 Pieters Ct, New Windsor, NY 12553
  • 157 Eaglesfield Way, Fairport, NY 14450
  • Penfield, NY
  • San Mateo, CA
  • Burlingame, CA

Publications

Us Patents

Compositions Relating To A Mutant Clostridium Difficile Toxin And Methods Thereof

View page
US Patent:
20130244307, Sep 19, 2013
Filed:
Mar 22, 2013
Appl. No.:
13/848909
Inventors:
Maninder K. Sidhu - New City NY, US
Robert G. K. Donald - South Orange NJ, US
Kathrin Ute Jansen - Allendale NJ, US
Narender K. Kalyan - Ridgewood NJ, US
Terri L. Mininni - New Windsor NY, US
Justin Keith Moran - Valley Cottage NY, US
Mark E. Ruppen - Garnerville NY, US
Michael James Flint - Decatur GA, US
Assignee:
WYETH LLC - MADISON NJ
International Classification:
C12N 15/74
US Classification:
4352523
Abstract:
In one aspect, the invention relates to an immunogenic composition that includes a mutant toxin A and/or a mutant toxin B. Each mutant toxin includes a glucosyltransferase domain having at least one mutation and a cysteine protease domain having at least one mutation, relative to the corresponding wild-type toxin. The mutant toxins may further include at least one amino acid that is chemically crosslinked. In another aspect, the invention relates to antibodies or binding fragments thereof that binds to said immunogenic compositions. In further aspects, the invention relates to isolated nucleotide sequences that encode any of the foregoing, and methods of use of any of the foregoing compositions.

Compositions Relating To A Mutant Clostridium Difficile Toxin And Methods Thereof

View page
US Patent:
20120269841, Oct 25, 2012
Filed:
Apr 20, 2012
Appl. No.:
13/451631
Inventors:
Maninder K. Sidhu - New City NY, US
Annaliesa Sybil Anderson - Upper Saddle River NJ, US
Robert G. K. Donald - South Orange NJ, US
Kathrin Ute Jansen - Allendale NJ, US
Narender K. Kalyan - Ridgewood NJ, US
Terri L. Mininni - New Windsor NY, US
Justin Keith Moran - Valley Cottage NY, US
Mark E. Ruppen - Garnerville NY, US
Michael James Flint - Decatur GA, US
Assignee:
WYETH LLC - Madison NJ
International Classification:
A61K 39/08
A61P 37/02
C07K 14/33
US Classification:
4241901, 530409
Abstract:
In one aspect, the invention relates to an immunogenic composition that includes a mutant toxin A and/or a mutant toxin B. Each mutant toxin includes a glucosyltransferase domain having at least one mutation and a cysteine protease domain having at least one mutation, relative to the corresponding wild-type toxin. The mutant toxins may further include at least one amino acid that is chemically crosslinked. In another aspect, the invention relates to antibodies or binding fragments thereof that binds to said immunogenic compositions. In further aspects, the invention relates to isolated nucleotide sequences that encode any of the foregoing, and methods of use of any of the foregoing compositions.
Control profile
Terri L Mininni from Peyton, CO, age ~65 Get Report